By Adam Lidgett (May 13, 2022, 7:19 PM EDT) -- India-based Emcure said Friday that it shouldn't have to face a suit launched in Washington federal court claiming it stole secrets for a new COVID-19 vaccine, saying Washington state isn't the right place for the claims.
Emcure Pharmaceuticals asked for dismissal of HDT Bio's March complaint. HDT Bio said its suit stems from Emcure's "blatant theft" of its "billion-dollar trade secrets" concerning "the most advanced vaccine technology in the world."
Emcure said that the court doesn't have personal jurisdiction over it and that, in any case, the right place for the suit would be in India, where Emcure operates from.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!